Christopher Statile
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher Statile has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Anita J. Moon Grady
University of California, San Francisco
2 shared publications - Ann Kavanaugh-McHugh
Department of Pediatrics (A.K.M.), Vanderbilt University Medical Center, Nashville, Tennessee, USA
2 shared publications Asela Nieuwsma
Texas Children’s Hospital and Baylor College of Medicine
2 shared publications- Bhawna Arya
Division of Cardiology, Seattle Children’s Hospital, University of Washington, Seattle, WA (B.A., S.B.K.).
2 shared publications - James Strainic
UH Rainbow Babies and Children’s Hospital, Cleveland, OH (J. Strainic)
2 shared publications Jeffrey B. Anderson
Department of Cardiology, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
2 shared publications
Latest Publications
- Open Access
- 4 November 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (21) , e040740
Use and Outcomes of the Medical Hybrid Procedure For Stage 1 Palliation in Infants With Hypoplastic Left Heart Syndrome and Variants
Background: Staged palliation of hypoplastic left heart syndrome and variants begins with the Norwood or hybrid procedure. Hybrid palliation is used in a minority of cases and often reserved for high‐risk patients. Stented hybrid (SH) comprises bilateral pulmonary artery bands and ductal stenting, and medical hybrid (MH) comprises bilateral pulmonary artery bands and prostaglandins. MH use and outcomes have not been well described. We sought to compare MH, SH, and surgical stage 1 (SS1) using a national database. Methods: Patients from the National Pediatric Cardiology Quality Improvement Collaborative database born between 2016 and 2021 were categorized by initial intervention: MH, SH, or SS1. Statistical comparisons and Kaplan–Meier analysis were performed. Results: This study included 2423 patients from 65 centers: 277 (11%) MH, 133 (5%) SH, and 2013 (83%) SS1. MH had lowest birth weight and gestational age, most noncardiac anomalies, and most preoperative risk factors. Most centers had minority MH, though use ranged from 0% to 82% at centers with ≥10 patients. Transplant‐free 1‐year survival was MH 56%, SH 66%, and SS1 81% ( P <0.0001). Using multivariable logistic regression, predictors of MH versus SS1 were lower birth weight, lower gestational age, genetic syndrome, noncardiac anomaly, and ≥4/12 preoperative risk factors. Predictors of MH versus SH were hypoplastic left heart syndrome and ≥4/12 preoperative risk factors. Cox proportional hazards regression showed MH had higher adjusted risk of 1‐year mortality/transplant compared with SS1 (hazard ratio [HR], 1.86 [95% CI, 1.44–2.39]) and no difference compared with SH (HR, 1.20 [95% CI, 0.84–1.70]). Conclusions: Survival after MH is similar to SH and worse than SS1. This may be due to patient risk factors not controlled for in this study.
- 4 November 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (21) , e040740
Open AccessUse and Outcomes of the Medical Hybrid Procedure For Stage 1 Palliation in Infants With Hypoplastic Left Heart Syndrome and Variants
Background: Staged palliation of hypoplastic left heart syndrome and variants begins with the Norwood or hybrid procedure. Hybrid palliation is used in a minority of cases and often reserved for high‐risk patients. Stented hybrid (SH) comprises bilateral pulmonary artery bands and ductal stenting, and medical hybrid (MH) comprises bilateral pulmonary artery bands and prostaglandins. MH use and outcomes have not been well described. We sought to compare MH, SH, and surgical stage 1 (SS1) using a national database. Methods: Patients from the National Pediatric Cardiology Quality Improvement Collaborative database born between 2016 and 2021 were categorized by initial intervention: MH, SH, or SS1. Statistical comparisons and Kaplan–Meier analysis were performed. Results: This study included 2423 patients from 65 centers: 277 (11%) MH, 133 (5%) SH, and 2013 (83%) SS1. MH had lowest birth weight and gestational age, most noncardiac anomalies, and most preoperative risk factors. Most centers had minority MH, though use ranged from 0% to 82% at centers with ≥10 patients. Transplant‐free 1‐year survival was MH 56%, SH 66%, and SS1 81% ( P <0.0001). Using multivariable logistic regression, predictors of MH versus SS1 were lower birth weight, lower gestational age, genetic syndrome, noncardiac anomaly, and ≥4/12 preoperative risk factors. Predictors of MH versus SH were hypoplastic left heart syndrome and ≥4/12 preoperative risk factors. Cox proportional hazards regression showed MH had higher adjusted risk of 1‐year mortality/transplant compared with SS1 (hazard ratio [HR], 1.86 [95% CI, 1.44–2.39]) and no difference compared with SH (HR, 1.20 [95% CI, 0.84–1.70]). Conclusions: Survival after MH is similar to SH and worse than SS1. This may be due to patient risk factors not controlled for in this study.
- Open Access
- 5 August 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (15) , e041677
Survival to Hospital Discharge in the Fetus With Moderate to Severe Mitral Regurgitation Either in Isolation or in Combination With Aortic Valve Stenosis or Atresia, a Fetal Heart Society Collaborative Study
Background: Case series report high mortality after fetal diagnosis of moderate to severe mitral regurgitation in combination with left atrial dilation, hydrops, or restrictive atrial septum. However, overall outcomes and specific high‐risk features remain unclear. Methods: We performed a multicenter retrospective cohort study of fetuses with ≥moderate mitral regurgitation and normal cardiac connections evaluated January 1, 2005 to January 31, 2016. Fetuses undergoing fetal cardiac intervention (FCI) were described separately. We assessed associations between fetal echocardiographic features and discharge mortality using mixed logistic regression and classification and regression tree modeling, stratified by studies performed Z score (OR per 1 unit increase, 0.61 [95% CI, 0.39–0.94]) remained in the model. By classification and regression tree modeling, left atrial dilation, restrictive atrial septum, and ascending aortic Z score <−1.3 were the key discriminators between survivors and nonsurvivors. Most FCIs were aortic valvuloplasty (13/16). Discharge mortality among FCI fetuses was 38%, not significantly different from non‐FCI once adjusting for mitral regurgitation and LA dilation. Conclusions: Fetal ≥moderate MsR is associated with high mortality. Left atrial dilation, restrictive atrial septum, and smaller ascending aorta confer highest risk for mortality.
- 5 August 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (15) , e041677
Open AccessSurvival to Hospital Discharge in the Fetus With Moderate to Severe Mitral Regurgitation Either in Isolation or in Combination With Aortic Valve Stenosis or Atresia, a Fetal Heart Society Collaborative Study
Background: Case series report high mortality after fetal diagnosis of moderate to severe mitral regurgitation in combination with left atrial dilation, hydrops, or restrictive atrial septum. However, overall outcomes and specific high‐risk features remain unclear. Methods: We performed a multicenter retrospective cohort study of fetuses with ≥moderate mitral regurgitation and normal cardiac connections evaluated January 1, 2005 to January 31, 2016. Fetuses undergoing fetal cardiac intervention (FCI) were described separately. We assessed associations between fetal echocardiographic features and discharge mortality using mixed logistic regression and classification and regression tree modeling, stratified by studies performed Z score (OR per 1 unit increase, 0.61 [95% CI, 0.39–0.94]) remained in the model. By classification and regression tree modeling, left atrial dilation, restrictive atrial septum, and ascending aortic Z score <−1.3 were the key discriminators between survivors and nonsurvivors. Most FCIs were aortic valvuloplasty (13/16). Discharge mortality among FCI fetuses was 38%, not significantly different from non‐FCI once adjusting for mitral regurgitation and LA dilation. Conclusions: Fetal ≥moderate MsR is associated with high mortality. Left atrial dilation, restrictive atrial septum, and smaller ascending aorta confer highest risk for mortality.
- Open Access
- 1 February 2022
- Published by Sociedad Argentina de Pediatria in Archivos Argentinos de Pediatria
- Vol. 120 (1)
Baja incidencia de cardiopatía clínicamente significativa en niños en edad escolar tras padecer COVID-19
- 1 February 2022
- Published by Sociedad Argentina de Pediatria in Archivos Argentinos de Pediatria
- Vol. 120 (1)
Open AccessBaja incidencia de cardiopatía clínicamente significativa en niños en edad escolar tras padecer COVID-19
- 9 June 2020
- Published by Wiley in Echocardiography
- Vol. 37 (7) , 1056-1064
Physician variation in ordering of transthoracic echocardiography in outpatient pediatric cardiac clinics
Background: The pediatric Appropriate Use Criteria (AUC) for outpatient transthoracic echocardiography (TTE) aim to reduce practice variation. Little is known on variation in TTE use between physicians. Understanding this variation will help identify areas for improvement in standardization of TTE use.Methods and Results: This is a retrospective review of initial outpatient visits at 6 pediatric cardiology centers in the United States prior to AUC release. Variation in TTE use was examined using multilevel generalized mixed effects models. Forward selection identified combinations of variables that explained the most variance in TTE use between physicians. Due to collinearity, physician compensation model and center were analyzed separately. Of 2883 encounters, the most common indication was murmur (36%), followed by chest pain (15.2%). Overall TTE use was 41.9%, and varied widely between centers (22.9%‐52.6%), and between physicians within centers. Center alone explained 29% of this physician variance. Adding physician characteristics increased the variance explained to 57%, which only minimally improved by adding patient characteristics. The variance explained was driven by subspecialty. The center‐based multivariable model explained more variance over compensation model.Conclusions: Center was the single largest determinant of physician variance in TTE use, followed by physician subspecialty. Efforts to reduce practice variation, such as the AUC, should be employed across centers and all pediatric cardiac providers. Center appears to have a stronger impact on variance than compensation model, though in this dataset the effect of center and compensation are hard to separate from each other and deserve further evaluation.
- 9 June 2020
- Published by Wiley in Echocardiography
- Vol. 37 (7) , 1056-1064
Physician variation in ordering of transthoracic echocardiography in outpatient pediatric cardiac clinics
Background: The pediatric Appropriate Use Criteria (AUC) for outpatient transthoracic echocardiography (TTE) aim to reduce practice variation. Little is known on variation in TTE use between physicians. Understanding this variation will help identify areas for improvement in standardization of TTE use.Methods and Results: This is a retrospective review of initial outpatient visits at 6 pediatric cardiology centers in the United States prior to AUC release. Variation in TTE use was examined using multilevel generalized mixed effects models. Forward selection identified combinations of variables that explained the most variance in TTE use between physicians. Due to collinearity, physician compensation model and center were analyzed separately. Of 2883 encounters, the most common indication was murmur (36%), followed by chest pain (15.2%). Overall TTE use was 41.9%, and varied widely between centers (22.9%‐52.6%), and between physicians within centers. Center alone explained 29% of this physician variance. Adding physician characteristics increased the variance explained to 57%, which only minimally improved by adding patient characteristics. The variance explained was driven by subspecialty. The center‐based multivariable model explained more variance over compensation model.Conclusions: Center was the single largest determinant of physician variance in TTE use, followed by physician subspecialty. Efforts to reduce practice variation, such as the AUC, should be employed across centers and all pediatric cardiac providers. Center appears to have a stronger impact on variance than compensation model, though in this dataset the effect of center and compensation are hard to separate from each other and deserve further evaluation.
- 1 March 2016
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 29 (3) , 247-252
Using Improvement Methodology to Optimize Echocardiographic Imaging of Coronary Arteries in Children
- 1 March 2016
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 29 (3) , 247-252
Using Improvement Methodology to Optimize Echocardiographic Imaging of Coronary Arteries in Children
- 1 March 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (5) , 652-655
Usefulness of Ventricular Premature Complexes in Asymptomatic Patients ≤21 Years as Predictors of Poor Left Ventricular Function
- 1 March 2015
- Published by Elsevier in The American Journal of Cardiology
- Vol. 115 (5) , 652-655
Usefulness of Ventricular Premature Complexes in Asymptomatic Patients ≤21 Years as Predictors of Poor Left Ventricular Function
- Open Access
- 1 January 2013
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 15 (1) , 67
Left ventricular noncompaction in Duchenne muscular dystrophy
- 1 January 2013
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 15 (1) , 67
Open AccessLeft ventricular noncompaction in Duchenne muscular dystrophy
- Open Access
- 24 September 2012
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 41 (1) , 54-58
Estimated cardiac output and cardiovascular profile score in fetuses with high cardiac output lesions
Objective: High cardiac output lesions are associated with an increased risk of fetal death, largely as a result of cardiac failure and hydrops fetalis. The cardiovascular profile score (CVPS) has been used to characterize cardiovascular wellbeing, and has been linked to fetal outcomes in other conditions. We aimed to test the hypothesis that elevated combined cardiac output (CCO) in fetuses with high output lesions may be associated with worsening cardiovascular status, as evidenced by a lower CVPS.Methods: A retrospective review was performed of fetuses with high cardiac output lesions that underwent echocardiography between July 2006 and November 2010. Diagnoses included sacrococcygeal teratoma, placental chorioangioma and vein of Galen aneurysm. Fetal echocardiographic evaluation included assessment of CVPS, as well as Doppler/two‐dimensional estimation of CCO, indexed to estimated fetal weight (CCOi). The relationship between CCO and CVPS was assessed.Results: A total of 35 fetuses were studied: 27 had sacrococcygeal teratoma, seven had chorioangioma and one had vein of Galen aneurysm. There was a significant inverse relationship between mean logCCOi and CVPS (r2 = 0.48, P = 0.008). Of 31 patients with clinical outcome data, 10 experienced either in‐utero demise or intervention; 80% of these fetuses had a CVPS of < 8.Conclusions: There is an inverse relationship between CCO and CVPS in the fetus with high cardiac output lesions. As a measure of fetal cardiovascular wellbeing in this population, the CVPS may be a useful tool for stratifying risk and for selection for intervention in these fetuses.
- 24 September 2012
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 41 (1) , 54-58
Open AccessEstimated cardiac output and cardiovascular profile score in fetuses with high cardiac output lesions
Objective: High cardiac output lesions are associated with an increased risk of fetal death, largely as a result of cardiac failure and hydrops fetalis. The cardiovascular profile score (CVPS) has been used to characterize cardiovascular wellbeing, and has been linked to fetal outcomes in other conditions. We aimed to test the hypothesis that elevated combined cardiac output (CCO) in fetuses with high output lesions may be associated with worsening cardiovascular status, as evidenced by a lower CVPS.Methods: A retrospective review was performed of fetuses with high cardiac output lesions that underwent echocardiography between July 2006 and November 2010. Diagnoses included sacrococcygeal teratoma, placental chorioangioma and vein of Galen aneurysm. Fetal echocardiographic evaluation included assessment of CVPS, as well as Doppler/two‐dimensional estimation of CCO, indexed to estimated fetal weight (CCOi). The relationship between CCO and CVPS was assessed.Results: A total of 35 fetuses were studied: 27 had sacrococcygeal teratoma, seven had chorioangioma and one had vein of Galen aneurysm. There was a significant inverse relationship between mean logCCOi and CVPS (r2 = 0.48, P = 0.008). Of 31 patients with clinical outcome data, 10 experienced either in‐utero demise or intervention; 80% of these fetuses had a CVPS of < 8.Conclusions: There is an inverse relationship between CCO and CVPS in the fetus with high cardiac output lesions. As a measure of fetal cardiovascular wellbeing in this population, the CVPS may be a useful tool for stratifying risk and for selection for intervention in these fetuses.